Your browser doesn't support javascript.
loading
Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study.
White, Helen E; Salmon, Matthew; Albano, Francesco; Andersen, Christina Søs Auður; Balabanov, Stefan; Balatzenko, Gueorgui; Barbany, Gisela; Cayuela, Jean-Michel; Cerveira, Nuno; Cochaux, Pascale; Colomer, Dolors; Coriu, Daniel; Diamond, Joana; Dietz, Christian; Dulucq, Stéphanie; Engvall, Marie; Franke, Georg N; Gineikiene-Valentine, Egle; Gniot, Michal; Gómez-Casares, María Teresa; Gottardi, Enrico; Hayden, Chloe; Hayette, Sandrine; Hedblom, Andreas; Ilea, Anca; Izzo, Barbara; Jiménez-Velasco, Antonio; Jurcek, Tomas; Kairisto, Veli; Langabeer, Stephen E; Lion, Thomas; Meggyesi, Nora; Mesanovic, Semir; Mihok, Luboslav; Mitterbauer-Hohendanner, Gerlinde; Moeckel, Sylvia; Naumann, Nicole; Nibourel, Olivier; Oppliger Leibundgut, Elisabeth; Panayiotidis, Panayiotis; Podgornik, Helena; Pott, Christiane; Rapado, Inmaculada; Rose, Susan J; Schäfer, Vivien; Touloumenidou, Tasoula; Veigaard, Christopher; Venniker-Punt, Bianca; Venturi, Claudia; Vigneri, Paolo.
Afiliação
  • White HE; Faculty of Medicine, University of Southampton, Southampton, UK.
  • Salmon M; Wessex Regional Genetics Laboratory, Salisbury NHS Foundation Trust, Salisbury, UK.
  • Albano F; Faculty of Medicine, University of Southampton, Southampton, UK.
  • Andersen CSA; Wessex Regional Genetics Laboratory, Salisbury NHS Foundation Trust, Salisbury, UK.
  • Balabanov S; Department of Emergency and Organ Transplantation (D.E.T.O.)-Hematology and Stem Cell Transplantation Unit, University of Bari "Aldo Moro", Bari, Italy.
  • Balatzenko G; Department of Pathology, Zealand University Hospital, Roskilde, Denmark.
  • Barbany G; Department of Medical Oncology and Hematology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Cayuela JM; Laboratory of Medical Genetics National Specialized Hospital for Active Treatment of Hematological Diseases, Sofia, Bulgaria.
  • Cerveira N; Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
  • Cochaux P; Laboratory of Hematology, University Hospital Saint-Louis, Université de Paris, Paris, France.
  • Colomer D; Department of Genetics and Research Centre, Portuguese Oncology Institute of Porto, Porto, Portugal.
  • Coriu D; Department of Molecular Hemato-Oncology, LHUB-ULB, Brussels, Belgium.
  • Diamond J; Pathology Department, Hospital Clinic, Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERONC, Barcelona, Spain.
  • Dietz C; Fundeni Clinical Institute, Hematology Department, Bucharest, Romania.
  • Dulucq S; Hematology Department, Faculty of Medicine, University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania.
  • Engvall M; Laboratório de Hemato-Oncologia-LHO Instituto Português de Oncologia Francisco Gentil, Lisbon, Portugal.
  • Franke GN; Institute for Hematology and Oncology (IHO GmbH), Mannheim, Germany.
  • Gineikiene-Valentine E; University Hospital of Bordeaux, Laboratory of Hematology, Haut Lévêque Hospital, Pessac, France.
  • Gniot M; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Gómez-Casares MT; University of Leipzig Medical Center, Department for Hematology, Cellular Therapies and Hemostaseology, Leipzig, Germany.
  • Gottardi E; Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
  • Hayden C; Poznan University of Medical Sciences, Department of Hematology and Bone Marrow Transplantation, Poznan, Poland.
  • Hayette S; Hematology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Las Palmas, Spain.
  • Hedblom A; Laboratory of Chemical and Clinical Analysis "Area 3" A.O.U San Luigi Gonzaga-Orbassano, Turin, Italy.
  • Ilea A; SIHMDS Hosted by Imperial College Healthcare NHS Trust at Hammersmith Hospital, London, UK.
  • Izzo B; Hospices Civils de Lyon, Hôpital Lyon Sud, Service d'Hématologie Biologique, Pierre-Bénite, France.
  • Jiménez-Velasco A; Section of Molecular Diagnostics, Clinical Genetics, Region Skåne, Lund, Sweden.
  • Jurcek T; Ritus Biotec Laboratory, Codlea-Brasov, Romania.
  • Kairisto V; Transilvania University, Brasov, Romania.
  • Langabeer SE; Department of Molecular Medicine and Medical Biotechnology University 'Federico II' and CEINGE-Advanced Biotechnologies, Naples, Italy.
  • Lion T; Hematology Department, Hospital Regional Universitario de Málaga, IBIMA, Málaga, Spain.
  • Meggyesi N; Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Mesanovic S; Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Mihok L; Department of Genomics, Turku University Hospital Laboratories, Turku, Finland.
  • Mitterbauer-Hohendanner G; Cancer Molecular Diagnostics, St. James's Hospital, Dublin, Ireland.
  • Moeckel S; Labdia Labordiagnostik/St. Anna Children´s Cancer Research Institute (CCRI), Vienna, Austria.
  • Naumann N; Laboratory of Molecular Genetics, Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases, Budapest, Hungary.
  • Nibourel O; Pathology Department, University Clinical Center Tuzla, Policlinic for Laboratory Diagnostics, Tuzla, Bosnia and Herzegovina.
  • Oppliger Leibundgut E; Department of Medical Genetics, National Cancer Institute, Bratislava, Slovakia.
  • Panayiotidis P; Medical University of Vienna, Department of Laboratory Medicine, Vienna, Austria.
  • Podgornik H; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Pott C; III. Medizinische Klinik, Universitätsmedizin Mannheim, Mannheim, Germany.
  • Rapado I; CHU Lille, Laboratoire d'hématologie, F-59000, Lille, France.
  • Rose SJ; University Hospital Bern, Bern, Switzerland.
  • Schäfer V; University of Bern, Bern, Switzerland.
  • Touloumenidou T; Haematology Research Laboratory, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Veigaard C; Department of Haematology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
  • Venniker-Punt B; Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
  • Venturi C; Second Medical Department, University Hospital Schleswig-Holstein, Campus Kiel, Germany.
  • Vigneri P; Hematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Imas12, 28041, Madrid, Spain.
Leukemia ; 36(7): 1834-1842, 2022 07.
Article em En | MEDLINE | ID: mdl-35614319
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article